Custom FISH probes, solid tumor probes, loci specific probes, and control probes.
Questions? Call 800-715-5880
New Products & Services
Empire Genomics (EG) is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. The EG services are designed to specifically meet the needs of pathologists, oncologists and researchers. Our mission is to address the problem the medical community faces with the rapid pace of molecular technology innovations, and the need for the delivery of clinically relevant, cost effective patient decision support tools. Ultimately, through our continued growth customers will be able to realize: faster and more effective drug development, lower healthcare costs, and better clinical outcomes for patients. Empire is uniquely positioned to bring this innovative service to the medical community through its highly qualified team, state of the art facilities and key strategic partnerships with leaders in the global research community. We are a resource to make personalized medicine a reality for you.
BAC Clones
Empire Genomics offers its customers access to over one million BAC clones as either bacterial stabs or purified DNA.
Custom Services
Empire Genomics offers an assortment of custom services to meet your research or clinical needs.
Genotyping
SNP analysis services let you measure genetic variations using either the Sequenom or Illumina Infinium platform.
Array CGH Services
Receive high-resolution evaluations of DNA copy number alterations associated with chromosome aberrations.
Circulating Tumor Cells
Easily count CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer.
Recent News
Patent ruling won't alter Empire Genomics approachA Buffalo biotech firm says the U.S. Supreme Court decision this week on patents and genetics won't likely have a major impact on its business, but th...
UB, Empire Genomics partner with Life Technologies to accelerate innovative, genetics-based clinical research in Western New York
Empire Genomics, Life Technologies Corporation and the University at Buffalo will embark on a new partnership to develop world-class gene sequencing f...
Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma
Empire Genomics, LLC (www.empiregenomics.com) has been awarded a Phase I SBIR Grant by the National Institute of Health/National Cancer Institute to d...